| GC35029-10mg |
|
108341-80-6 |
1-Arachidoyl-sn-glycero-3-phosphocholine
|
0 |
C28H58NO7P |
|
|
|
| GC35028-5mg |
|
— |
[SER140]-PLP(139-151) TFA
|
0 |
C74H105F3N20O19 |
|
|
|
| GC35028-1mg |
|
— |
[SER140]-PLP(139-151) TFA
|
0 |
C74H105F3N20O19 |
|
|
|
| GC35026-50mg |
|
— |
[Sar1, Ile8]-Angiotensin II TFA
|
0 |
C48H74F3N13O12 |
|
|
|
| GC35026-10mg |
|
— |
[Sar1, Ile8]-Angiotensin II TFA
|
0 |
C48H74F3N13O12 |
|
|
|
| GC35026-10mM (in 1mL DMSO) |
|
— |
[Sar1, Ile8]-Angiotensin II TFA
|
0 |
C48H74F3N13O12 |
|
|
|
| GC35025-50mg |
|
37827-06-8 |
[Sar1, Ile8]-Angiotensin II
|
0 |
C46H73N13O10 |
|
|
|
| GC35025-10mg |
|
37827-06-8 |
[Sar1, Ile8]-Angiotensin II
|
0 |
C46H73N13O10 |
|
|
|
| GC35019-10mg |
|
57462-42-7 |
|
0 |
C64H100N18O13 |
|
|
|
| GC35019-5mg |
|
57462-42-7 |
|
0 |
C64H100N18O13 |
|
|
|
| GC35019-1mg |
|
57462-42-7 |
|
0 |
C64H100N18O13 |
|
|
|
| GC35018-25mg |
|
— |
[Met5]-Enkephalin, amide TFA
|
0 |
C29H37F3N6O8S |
|
|
|
| GC35018-10mg |
|
— |
[Met5]-Enkephalin, amide TFA
|
0 |
C29H37F3N6O8S |
|
|
|
| GC35017-25mg |
|
60117-24-0 |
|
0 |
C28H38N6O6 |
|
|
|
| GC35017-10mg |
|
60117-24-0 |
|
0 |
C28H38N6O6 |
|
|
|
| GC35015-25mg |
|
15958-92-6 |
|
0 |
C44H61N11O10 |
|
|
|
| GC35015-10mg |
|
15958-92-6 |
|
0 |
C44H61N11O10 |
|
|
|
| GC35015-5mg |
|
15958-92-6 |
|
0 |
C44H61N11O10 |
|
|
|
| GC35013-5mg |
|
36700-45-5 |
|
0 |
C19H28O3 |
|
|
|
| GC35012-5mg |
|
36752-54-2 |
|
0 |
C21H32O3 |
|
|
|
